Mountain Valley MD Holdings Inc (fra:20MP) Share Price

Company Profile

Business description
Mountain Valley MD Holdings Inc is a Canada-based company. The firm, along with its subsidiaries, is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The company actively invests in and collaborates on pioneering biotechnologies that have the potential to revolutionize the human health and wellness landscape, drive sustainable increases in plant yields and agricultural farming practices, and broadly support animal husbandry health. The Company is a biotech company focused on advancing solutions to optimize human, animal, and plant health.
Contact
260 Edgeley Boulevard
Unit 4
VaughanONL6K 3Y4
CAN
T: +1 647 725-9755
https://www.mountainvalleymd.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees

Recommended

We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.

Brian Colello, CPA | 19 September 2025

Our Fair Value estimate once again reflects the stand-alone business and its growth potential.

Mark Taylor | 19 September 2025

Coverage of ASX listed REIT as investor interest in property continues to grow.

Yingqi Tan, CFA | 19 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,085.20	37.30	-0.41%
CAC 40	7,854.61	36.39	0.47%
DAX 40	23,674.53	315.35	1.35%
Dow JONES (US)	46,142.42	124.10	0.27%
FTSE 100	9,228.11	32.45	0.35%
HKSE	26,576.59	138.08	0.52%
NASDAQ	22,470.72	209.40	0.94%
Nikkei 225	44,752.32	149.95	-0.33%
NZX 50 Index	13,179.13	55.76	-0.42%
S&P 500	6,631.96	31.61	0.48%
S&P/ASX 200	8,797.60	50.90	-0.58%
SSE Composite Index	3,830.65	1.00	-0.03%